A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
Health Commure Autonomous Coding Scales to 200+ Sites with OBHGHealthradar4. Dezember 2025 What You Should Know: – Commure, a healthcare technology company, and Ob Hospitalist Group (OBHG), the nation’s largest provider of…
